IP Verse

Wyeth Llc opposition analysis

COMPANY ANALYSIS

Latest patents of Wyeth Llc opposed by its competitors

Patent:
EP2676679
Grant Date:
Aug 28, 2024
Title:
Formulations Which Stabilize And Inhibit Precipitation Of Immunogenic Compositions
Oppositions:
3
Patent:
EP3246044
Grant Date:
Apr 10, 2024
Title:
Stable Formulations Of Neisseria Meningitidis Rlp2086 Antigens
Oppositions:
1
Patent:
EP3175853
Grant Date:
Nov 1, 2023
Title:
Antineoplastic Combinations Of Neratinib And Capecitabine
Oppositions:
1
Patent:
EP1942868
Grant Date:
Oct 4, 2023
Title:
Sodium Chloride Solution For Drug Reconstitution Or Dilution
Oppositions:
1
Patent:
EP3263571
Grant Date:
Aug 23, 2023
Title:
Crystal Form Of (R)-N-Methylnaltrexone Bromide And Uses Thereof
Oppositions:
1
Patent:
EP3000467
Grant Date:
Mar 1, 2023
Title:
Treatment Regimen Utilizing Neratinib For Breast Cancer
Oppositions:
3
Patent:
EP2498756
Grant Date:
Feb 15, 2023
Title:
Tablet Formulations Of Neratinib Maleate
Oppositions:
1
Patent:
EP3255141
Grant Date:
Dec 1, 2021
Title:
Production Of Antibodies With Improved Glycosylation Pattern
Oppositions:
2
Patent:
EP3002009
Grant Date:
Jul 7, 2021
Title:
Treatment Of Imatinib Resistant Leukemia Using 4-Aminoquinoline-3-Carbonitriles
Oppositions:
1
Patent:
EP3549601
Grant Date:
Feb 24, 2021
Title:
Non-Lipidated Variants Of Neisseria Meningitidis Orf2086 Antigens
Oppositions:
1

Competitors of Wyeth Llc

STRAWMAN LIMITED

SANDOZ AG

SANOFI PASTEUR

Want to track Wyeth Llc?

Feel free to send us a message here and we will get back to you